YKL050C Antibody (Product Code: CSB-PA339581XA01SVG) is a rabbit-derived polyclonal antibody raised against the recombinant YKL050C protein . It specifically recognizes the YKL050C gene product, a peroxisomal matrix protein recently identified as a lipase named Lpx2 (Lipase of Peroxisomes 2) .
Peroxisomal Localization: YKL050C (Lpx2) localizes to peroxisomes and interacts with Pex5, a receptor for peroxisomal matrix protein import .
Lipid Metabolism: Lipidomic analyses revealed that Δykl050c strains accumulate LPG, suggesting its role in phospholipid degradation .
Enzymatic Activity: YKL050C demonstrates hydrolytic activity against lipid substrates, positioning it as a therapeutic target for lipid-related disorders .
Western Blot: The antibody reliably detects YKL050C in yeast lysates, confirming its specificity .
Yeast-Two-Hybrid Assays: Validated interactions between YKL050C and peroxisomal import machinery components .
| Lipid Class | Change in Δykl050c vs. Wild-Type | p-value |
|---|---|---|
| Lyso-Phosphatidylglycerol (LPG) | ↑ 2.5-fold | <0.01 |
| Triacylglycerol (TAG) | ↓ 1.8-fold | <0.05 |
| Application | Dilution Range | Validation Status |
|---|---|---|
| ELISA | 1:1,000–1:5,000 | Confirmed |
| WB | 1:500–1:2,000 | Verified |
YKL050C is a protein found in Saccharomyces cerevisiae (Baker's yeast), specifically in strain ATCC 204508 / S288c, associated with UniProt accession number P35736 . The protein serves as an important target in basic yeast research to understand fundamental cellular processes in this model organism. Antibodies against YKL050C provide valuable tools for detecting, quantifying, and studying this protein in various experimental contexts. The applications include protein expression analysis, protein localization studies, and investigation of protein-protein interactions within yeast cells. YKL050C research contributes to our broader understanding of eukaryotic cellular mechanisms, as S. cerevisiae often serves as a model system for more complex organisms.
YKL050C antibody has been specifically tested and validated for applications including ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot (WB) to ensure accurate identification of the antigen . These techniques allow researchers to detect and quantify YKL050C protein in different experimental settings. For ELISA applications, the antibody enables quantification of YKL050C in solution, while Western Blot applications facilitate detection of the protein in cell lysates separated by gel electrophoresis. The polyclonal nature of this antibody provides recognition of multiple epitopes on the YKL050C protein, potentially increasing detection sensitivity compared to monoclonal antibodies that recognize only a single epitope. Researchers should always validate the antibody in their specific experimental system for optimal results.
The YKL050C antibody requires storage at either -20°C or -80°C upon receipt to maintain its activity and specificity . The antibody is supplied in liquid formulation containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . This formulation helps maintain antibody stability during freeze-thaw cycles, though repeated freeze-thaw should be avoided to prevent degradation of the antibody . For working solutions needed within one week, short-term storage at 4°C is acceptable. Best practices include aliquoting the antibody into smaller volumes before freezing to minimize freeze-thaw cycles. Proper adherence to these storage guidelines is crucial for maintaining antibody functionality and ensuring reliable, reproducible experimental results.
Verifying YKL050C antibody specificity requires a systematic validation approach involving multiple controls and techniques:
Positive control analysis using purified recombinant YKL050C protein to confirm specific binding
Negative control testing with YKL050C knockout or depleted yeast samples to evaluate background signal
Western blot analysis to confirm detection of a single band at the expected molecular weight
Cross-reactivity assessment against closely related yeast proteins to determine antibody exclusivity
Pre-absorption controls using excess antigen to confirm signal elimination through specific binding
Additional validation can include immunoprecipitation followed by mass spectrometry analysis to confirm the identity of the pulled-down protein. For advanced structural characterization, techniques like cryoEM can be employed to map epitope binding sites . Complete validation ensures that experimental results accurately reflect YKL050C biology rather than artifacts from non-specific interactions or cross-reactivity with other yeast proteins.
The YKL050C antibody available for research is a polyclonal antibody produced in rabbits . This classification has significant implications for its research applications:
| Characteristic | Polyclonal YKL050C Antibody | Monoclonal Antibodies |
|---|---|---|
| Production | Multiple B-cell lineages in immunized rabbit | Single B-cell clone |
| Epitope recognition | Multiple epitopes on YKL050C | Single epitope |
| Sensitivity | Generally higher due to multiple binding sites | Potentially lower but more consistent |
| Batch-to-batch variation | Moderate to high | Minimal |
| Application flexibility | Works across multiple applications | May be optimized for specific applications |
| Denaturation tolerance | Higher tolerance to protein denaturation | May lose binding if epitope is altered |
Optimizing Western blot protocols for YKL050C detection requires careful attention to multiple parameters:
Sample Preparation:
Extract yeast proteins using mechanical disruption (glass beads) or enzymatic methods (zymolyase)
Include protease inhibitor cocktail to prevent YKL050C degradation
Maintain samples at 4°C during processing
Denature proteins completely in SDS loading buffer at 95°C for 5 minutes
Gel Electrophoresis:
Use 10-12% SDS-PAGE gels for optimal resolution
Load 20-50 μg total protein per lane (optimize based on YKL050C expression level)
Include positive control (known YKL050C-expressing sample)
Run gel at 100-120V until adequate separation is achieved
Transfer Conditions:
Use PVDF membrane (0.45 μm pore size) for better protein retention
Transfer at 100V for 1 hour or 30V overnight at 4°C
Verify transfer efficiency with reversible protein stain
Antibody Incubation:
Block membrane with 5% non-fat dry milk or 3% BSA in TBST for 1 hour at room temperature
Dilute YKL050C antibody according to manufacturer recommendations (typically 1:1000-1:2000)
Incubate with primary antibody overnight at 4°C with gentle rocking
Wash membrane extensively with TBST (4-5 times, 5-10 minutes each)
Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000-1:10000) for 1 hour
Detection and Documentation:
Develop using enhanced chemiluminescence (ECL) substrate
Optimize exposure time to avoid signal saturation
Document results with digital imaging system for quantitative analysis
This optimized protocol provides a methodological framework that researchers can adapt based on their specific experimental conditions and equipment.
CryoEM (cryogenic electron microscopy) offers advanced structural insights into YKL050C antibody-antigen interactions at near-atomic resolution. Based on similar approaches in antibody research , a methodological workflow would include:
Complex Formation:
Purify recombinant YKL050C protein to >95% homogeneity
Generate Fab fragments from YKL050C antibody using papain digestion
Form stable antibody-antigen complexes using 3:1 molar ratio of Fab to antigen
Purify complexes by size exclusion chromatography
CryoEM Sample Preparation:
Apply 3-4 μL purified complex to glow-discharged grids
Blot excess solution (4-5 seconds) and plunge-freeze in liquid ethane
Store grids in liquid nitrogen until imaging
Data Collection and Processing:
Collect micrographs using direct electron detector with dose fractionation
Process image stacks with motion correction and CTF estimation
Perform particle picking, 2D classification, and 3D reconstruction
Refine the 3D structure to high resolution (ideally <4Å)
Epitope Mapping and Model Building:
Binding Affinity Characterization:
This approach provides detailed molecular understanding of antibody specificity, potentially revealing conformational epitopes and binding mechanisms that inform experimental design and interpretation.
Epitope accessibility significantly affects YKL050C antibody binding efficiency across different experimental applications. Researchers must consider several determinants:
Protein Conformation Influences:
Native vs. denatured conditions alter epitope exposure
Reducing agents (β-mercaptoethanol, DTT) disrupt disulfide bonds, potentially revealing hidden epitopes
Applications requiring native protein (immunoprecipitation) may experience reduced antibody binding if epitopes are conformationally masked
Sample Preparation Effects:
Fixation methods (formaldehyde, methanol) can alter protein structure and epitope accessibility
Heat-induced antigen retrieval may recover epitopes masked by fixation
Detergent selection affects membrane protein solubilization and epitope exposure
Application-Specific Considerations:
| Application | Key Accessibility Factors | Optimization Approaches |
|---|---|---|
| Western Blot | Complete denaturation for linear epitope access | SDS and heat treatment, reducing conditions |
| Immunoprecipitation | Preserving native structure while exposing epitopes | Gentle non-ionic detergents, salt optimization |
| ELISA | Consistent antigen coating and presentation | Optimize coating buffer pH, blocking conditions |
| Immunofluorescence | Fixation and permeabilization balance | Test multiple fixatives, antigen retrieval methods |
Environmental Variables:
Buffer pH alters protein charge distribution and conformation
Ionic strength affects antibody-antigen interaction strength
Temperature influences both protein conformation and binding kinetics
Systematic optimization of these parameters is essential for maximizing specific detection while minimizing background signal. Researchers should document conditions that successfully expose YKL050C epitopes for each application.
When facing inconsistent results with YKL050C antibody, a methodical troubleshooting approach is essential:
Antibody Quality Assessment:
Verify antibody integrity by checking expiration date and storage history
Test activity using dot blot with purified antigen
Consider antibody degradation if multiple freeze-thaw cycles have occurred
Compare results between different antibody lots if available
Sample Preparation Evaluation:
Confirm complete cell lysis and protein extraction
Assess protein degradation using Coomassie staining of total protein
Add additional protease inhibitors if degradation is suspected
Verify sample concentration and loading consistency
Protocol Optimization Matrix:
| Parameter | Test Range | Evaluation Method |
|---|---|---|
| Antibody Dilution | 1:500 to 1:5000 | Signal-to-noise ratio |
| Blocking Agent | Milk vs. BSA vs. Casein | Background reduction |
| Incubation Time | 1h to overnight | Signal intensity |
| Washing Stringency | 3-6 washes, 5-15 min each | Background reduction |
| Detection Method | Chemiluminescence vs. fluorescence | Sensitivity and linearity |
Application-Specific Troubleshooting:
For Western blot: Optimize transfer conditions, membrane type
For ELISA: Adjust coating concentration, blocking formulation
For IP: Test different lysis buffers, bead types
Systematic Documentation:
Create a detailed troubleshooting log recording all variables
Test one parameter at a time to identify critical factors
Document successful conditions for future reference
Through this systematic approach, researchers can identify sources of variability and establish reliable protocols for consistent YKL050C detection across experiments.
Designing effective co-immunoprecipitation (co-IP) experiments with YKL050C antibody requires careful consideration of experimental conditions to preserve protein-protein interactions while ensuring specific isolation:
Experimental Design Considerations:
Lysis Optimization:
Use gentle lysis buffers to preserve interactions (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40)
Include protease inhibitor cocktail to prevent degradation
Perform lysis at 4°C to minimize protein denaturation
Antibody Binding Strategy:
Pre-bind YKL050C antibody to protein A/G beads (2-5 μg antibody per experiment)
Pre-clear lysates with beads alone to reduce non-specific binding
Optimize antibody-to-lysate ratio for maximum specific pull-down
Control Implementation:
| Control Type | Purpose | Implementation |
|---|---|---|
| Negative Control | Assess non-specific binding | IP with non-specific rabbit IgG |
| Input Control | Verify protein presence | Analyze 5-10% of pre-IP lysate |
| Specificity Control | Confirm antibody specificity | Compete with excess antigen |
| Reciprocal IP | Validate interactions | IP with antibodies against binding partners |
Interaction Preservation:
Optimize salt concentration (100-300 mM) to balance specificity with interaction maintenance
Test different detergents (NP-40, Triton X-100, Digitonin) for optimal solubilization
Consider chemical crosslinking for transient interactions
Detection Methods:
Data Analysis:
Quantify enrichment relative to negative controls
Determine reproducibility across biological replicates
Validate key interactions with orthogonal methods
This methodological framework provides a systematic approach to identifying YKL050C protein interaction partners while minimizing artifacts from non-specific binding or post-lysis interactions.
Integrating YKL050C antibody with advanced structural biology techniques enables comprehensive characterization of protein structure, function, and interactions:
CryoEM Integration:
Use YKL050C antibody fragments (Fab) as fiducial markers for orientation determination in cryoEM
Apply cryoEM polyclonal epitope mapping (cryoEMPEM) to identify antibody binding sites
Generate 3D reconstructions of antibody-antigen complexes at near-atomic resolution
Build atomic models into density maps to visualize binding interfaces
Structural Mapping Workflow:
Generate and validate antibody-antigen complexes
Collect high-resolution cryoEM data
Process data using classification algorithms to separate heterogeneous populations
Perform 3D reconstruction and model building
Annotate epitopes and interaction surfaces
Integrative Structural Approaches:
| Technique | Information Provided | Integration with Antibody |
|---|---|---|
| X-ray Crystallography | Atomic resolution structure | Co-crystallization with Fab fragments |
| Hydrogen-Deuterium Exchange | Solvent accessibility, dynamics | Compare exchange rates with/without antibody |
| Cross-linking Mass Spectrometry | Spatial proximity of residues | Identify residues protected by antibody binding |
| Small-Angle X-ray Scattering | Solution-state molecular envelope | Validate complex formation and conformation |
Advanced Applications:
Epitope mapping through negative-stain electron microscopy followed by cryoEM refinement
Combining computational modeling with experimental validation of antibody-antigen interfaces
Using antibodies to stabilize flexible regions for structural determination
Correlating structural information with functional assays to connect structure to function
This integrative approach leverages YKL050C antibody beyond traditional applications, providing deeper molecular insights into protein structure and function in the context of the cellular environment.